OGN) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 5.3% year on year to $1.51 billion ... Organon (OGN) Q4 CY2025 Highlights. ... OGN) is a global healthcare company focused on ...
Pharmaceutical company Organon (NYSE. OGN) will be announcing earnings results this Thursday morning. Here’s what you need to know ... Is Organon a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members ... More News ... .
What Happened?. Shares of pharmaceutical company Organon (NYSE. OGN) jumped 8.9% in the afternoon session after reports surfaced that Sun Pharmaceutical Industries submitted a non-binding proposal to acquire the company ... More News. ViewMore ... Tickers ATO.
What Happened?. Shares of pharmaceutical company Organon (NYSE. OGN) fell 4.7% in the afternoon session after Barclays initiated coverage on the company with an 'Underweight' rating and a price target of $7.50... More News. ViewMore ... Via MarketBeat ... .
Over the past six months, Organon’s stock price fell to $7.77 ... This may have investors wondering how to approach the situation ... Why Is Organon Not Exciting? ... Here are three reasons there are better opportunities than OGN and a stock we'd rather own. 1 ... 2.
What Happened?. Shares of pharmaceutical company Organon (NYSE. OGN) fell 2.9% in the afternoon session after the company lowered its full-year sales guidance and analysts subsequently cut their price targets on the stock ... More News. ViewMore ... View More.
OGN) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 1.3% year on year to $1.60 billion ... Organon (OGN) Q3 CY2025 Highlights. ... OGN) is a global healthcare company ...